Ryman Healthcare Limited (RYHTY)
OTCMKTS
· Delayed Price · Currency is USD
14.11
0.00 (0.00%)
Aug 29, 2024, 4:00 PM EDT
Ryman Healthcare Revenue
In the fiscal year ending March 31, 2024, Ryman Healthcare had annual revenue of 687.56M NZD with 18.22% growth. Ryman Healthcare had revenue of 365.87M in the half year ending March 31, 2024, with 40.22% growth.
Revenue
687.56M NZD
Revenue Growth
+18.22%
P/S Ratio
23.58
Revenue / Employee
89.29K NZD
Employees
7,700
Market Cap
2.08B USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 687.56M | 105.95M | 18.22% |
Mar 31, 2023 | 581.61M | 72.86M | 14.32% |
Mar 31, 2022 | 508.76M | 53.07M | 11.64% |
Mar 31, 2021 | 455.69M | 32.36M | 7.64% |
Mar 31, 2020 | 423.34M | 41.53M | 10.88% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Verano Holdings Corp. | 920.97M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 108.78M |
Telescope Innovations Corp. | 2.86M |
Zeo ScientifiX, Inc. | 4.93M |
Ryman Healthcare News
- 4 weeks ago - Ryman Healthcare bombshell: reviewing fixed weekly fees, DMF for new residents - NZ Herald
- 2 months ago - How Ryman Healthcare chairman Dean Hamilton plans to fix a financial disaster - NZ Herald